Ginkgo Bioworks Holdings, Inc.

Soaring Eagle Acquisition Corp., trading under ticker SRNG, was a blank-check company that completed its initial public offering in February 2021 and is sponsored by Eagle Equity Partners, the vehicle associated with veteran SPAC managers Harry Sloan and Jeff Sagansky. The SPAC targeted the life sciences and synthetic biology sector, and in May 2021 announced a definitive agreement to combine with Ginkgo Bioworks, a Boston-based synthetic biology platform company. The transaction closed in September 2021, with the combined entity operating as Ginkgo Bioworks Holdings, Inc. This 10-Q, filed May 24, 2021, covers the SPAC's pre-close reporting period. Sign up at SpacDesk for full filings, deal timelines, and sponsor analytics on this and every active SPAC.